Protalix BioTherapeutics, Inc. (PLX)
USD 1.71
(-1.72%)
USD 1.71
(-1.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.31 Million | -25 Million | -10.28 Million | -26.1 Million | -19.35 Million | -7.74 Million |
| Net Income | 8.31 Million | -14.92 Million | -27.58 Million | -6.52 Million | -18.27 Million | -26.45 Million |
| Depreciation & Amortization | 1.19 Million | 1.08 Million | 1.11 Million | 1.3 Million | 1.61 Million | 1.67 Million |
| Deferred income taxes | -3.09 Million | - | 813 Thousand | -522 Thousand | -68 Thousand | -64 Thousand |
| Stock-based compensation | 3.44 Million | 2.08 Million | 2.37 Million | 3.12 Million | 835 Thousand | 514 Thousand |
| Change in working capital | -10.53 Million | -12.01 Million | 9.9 Million | -27.13 Million | -6.83 Million | 13.52 Million |
| Other non-cash items | -637.99 Thousand | -1.22 Million | 3.09 Million | 3.64 Million | 3.36 Million | 3.06 Million |
| Investing Cash Flow | -16.71 Million | -5.03 Million | 18.92 Million | -19.95 Million | -883 Thousand | -591 Thousand |
| Investments in PPE | -1.14 Million | -628 Thousand | -1.45 Million | -655 Thousand | -627 Thousand | -686 Thousand |
| Acquisitions | 15.42 Million | - | 53 Thousand | - | - | - |
| Investment purchases | -20.42 Million | -16 Million | -37.83 Million | -20 Million | - | - |
| Sales/Maturities of investments | 5 Million | 11 Million | 57.83 Million | - | - | - |
| Other Investing Activities | -15.56 Million | 593 Thousand | 327 Thousand | 703 Thousand | -256 Thousand | 95 Thousand |
| Financing Cash Flow | 24.66 Million | 8.23 Million | 12.07 Million | 46.46 Million | - | -4.75 Million |
| Debt repayment | - | - | -34.12 Million | -215 Thousand | - | -4.75 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 24.66 Million | 8.23 Million | 46.2 Million | 46.21 Million | - | - |
| Other Financing Activities | 712 Thousand | 2000.00 | 42.11 Million | 472 Thousand | - | -4.75 Million |
| Accounts receivables | -428 Thousand | -1.19 Million | -1.03 Million | 2.09 Million | 188 Thousand | -3.09 Million |
| Accounts payables | 5.29 Million | -4.8 Million | 2.57 Million | 1.91 Million | 2.14 Million | -520 Thousand |
| Inventory | -2.24 Million | 1.15 Million | -4.87 Million | -4.92 Million | 414 Thousand | -736 Thousand |
| Other working capital | -13.16 Million | -7.16 Million | 13.23 Million | -26.2 Million | -9.58 Million | 17.88 Million |
| Cash at beginning of period | 17.11 Million | 38.98 Million | 18.26 Million | 17.79 Million | 37.8 Million | 51.16 Million |
| Cash at end of period | 23.63 Million | 17.11 Million | 38.98 Million | 18.26 Million | 17.79 Million | 37.8 Million |
| Capital Expenditure | -1.14 Million | -628 Thousand | -1.45 Million | -655 Thousand | -627 Thousand | -686 Thousand |
| Effect of forex changes on cash | -114 Thousand | -77 Thousand | 6000.00 | 64 Thousand | 225 Thousand | -270 Thousand |
| Net cash flow / Change in cash | 6.52 Million | -21.87 Million | 20.72 Million | 473 Thousand | -20.01 Million | -13.35 Million |
| Free Cash Flow | -2.46 Million | -25.62 Million | -11.74 Million | -26.76 Million | -19.98 Million | -8.42 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.2 Million | -4.59 Million | -6.04 Million | 8.31 Million | -1.85 Million | 19.33 Million |
| Depreciation & Amortization | 319 Thousand | 322 Thousand | 313 Thousand | 1.19 Million | 305 Thousand | 293 Thousand |
| Deferred income taxes | -69 Thousand | -138 Thousand | 3.09 Million | -3.09 Million | 38 Thousand | -3.14 Million |
| Stock-based compensation | 998 Thousand | 981 Thousand | 1.36 Million | 3.44 Million | 1.09 Million | 438 Thousand |
| Change in working capital | -2.15 Million | 8.08 Million | 7.77 Million | -10.53 Million | -6.06 Million | -11.54 Million |
| Other non-cash items | -2.1 Million | 5.87 Million | -2.9 Million | -637.99 Thousand | -407 Thousand | -414 Thousand |
| Investing Cash Flow | -180 Thousand | -606 Thousand | -342 Thousand | -16.71 Million | -20.87 Million | -222 Thousand |
| Investments in PPE | -172 Thousand | -598 Thousand | -250 Thousand | -1.14 Million | -447 Thousand | -204 Thousand |
| Acquisitions | - | - | - | 15.42 Million | - | - |
| Investment purchases | - | - | - | -20.42 Million | - | - |
| Sales/Maturities of investments | - | - | - | 5 Million | - | -5 Million |
| Other Investing Activities | -8000.00 | -8000.00 | -92 Thousand | -15.56 Million | -20.43 Million | 4.98 Million |
| Financing Cash Flow | - | - | - | 24.66 Million | - | 10.43 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 24.66 Million | - | 9.72 Million |
| Other Financing Activities | - | - | -14.23 Million | 712 Thousand | - | 712 Thousand |
| Accounts receivables | -7.05 Million | 1.74 Million | 3.76 Million | -428 Thousand | -4.3 Million | -3.7 Million |
| Accounts payables | 1.61 Million | -1.41 Million | 1.47 Million | 5.29 Million | 177 Thousand | 3.29 Million |
| Inventory | 1.62 Million | -3.3 Million | 2.53 Million | -2.24 Million | -1.94 Million | 668 Thousand |
| Other working capital | -5.39 Million | 12.79 Million | 1000.00 | -13.16 Million | 9000.00 | -11.79 Million |
| Cash at beginning of period | 27.2 Million | 23.63 Million | 20.4 Million | 17.11 Million | 48.18 Million | 33.03 Million |
| Cash at end of period | 23.39 Million | 27.2 Million | 23.63 Million | 23.63 Million | 20.4 Million | 48.18 Million |
| Capital Expenditure | -172 Thousand | -598 Thousand | -250 Thousand | -1.14 Million | -447 Thousand | -204 Thousand |
| Effect of forex changes on cash | -20 Thousand | -7000.00 | -27 Thousand | -114 Thousand | -9000.00 | -36 Thousand |
| Net cash flow / Change in cash | -3.81 Million | 3.57 Million | 3.22 Million | 6.52 Million | -27.77 Million | 15.14 Million |
| Free Cash Flow | -3.78 Million | 3.58 Million | 3.34 Million | -2.46 Million | -7.33 Million | 4.76 Million |
CGS
SBTX
KKPNF
RCL
SCC-R
6038